Login / Signup

Safety of Nebulized Colistin Solution as Adjunctive Treatment of Lower Respiratory Tract Infections.

Komal NadeemKaran RajaMark AttallaMitesh PatelMona Philips
Published in: Journal of pharmacy practice (2020)
The results of our study signify localized administration of colistin results in a low incidence of systemic adverse events. Nebulized colistin is a safe adjunct for managing LRTI.
Keyphrases
  • acinetobacter baumannii
  • escherichia coli
  • respiratory tract
  • klebsiella pneumoniae
  • pseudomonas aeruginosa
  • gram negative
  • multidrug resistant
  • drug resistant
  • cystic fibrosis